Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:38 PM
Ignite Modification Date:
2025-12-24 @ 1:38 PM
NCT ID:
NCT00804895
Eligibility Criteria:
Inclusion Criteria:
* patient age, man or woman whose age is between 18 and 65 included
* patient who signed a free express and informed consent
* patient with cluster headache, episodic or chronic according to the criteria of International Headache Society (ICHD-II)
* patient with more than two episodes of CH per day
* patient with a normal medical examination
Exclusion Criteria:
* patient not affiliated with a social security scheme (or beneficiary entitled)
* patient with another diagnosis ICHD-II,and being unable to differentiate CH attacks from its other cranial pain
* patient of CH having started his episodic active period more than 30 days ago
* patient with a contra-indication to verapamil
* patient with a known allergy to cortivazol
* patient with anticoagulant therapy or having a bleeding disorder
* patient unable to complete the schedule crisis
* patient non-compliant or unable to follow the research protocol
* women without contraception, pregnant, or nursing
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00804895
Study Brief:
Protocol Section:
NCT00804895